Lee, Zhen-Vin
Llanes, Elmer Jasper
Sukmawan, Renan
Thongtang, Nuntakorn
Ho, Huynh Quang Tri
Barter, Philip
,
Article History
Received: 19 August 2020
Accepted: 2 March 2021
First Online: 15 April 2021
Declarations
:
: Not applicable.
: Not applicable.
: Zhen-Vin Lee has received honoraria from Aspen, AstraZeneca, Bayer, Boehringer Ingelheim, Merck, Merck Sharp & Dohme, Novartis, Pfizer Upjohn, and Servier. Renan Sukmawan has received speaker’s fees and honoraria for ad boards from AstraZeneca, Merck Sharp & Dohme, Mitsubishi Tanabe Pharma, and Pfizer Upjohn. Nuntakorn Thongtang has received research funding from Pfizer Upjohn. Ho Huynh Quang Tri has received speaker’s fees from Pfizer Upjohn, AstraZeneca, and Merck Sharp & Dohme. Philip Barter has received honoraria for consultancies and ad boards from Pfizer Upjohn and Amgen. Elmer Llanes has received speaker’s fees from AstraZeneca, Orient EuroPharma, Merck Sharp & Dohme, and LRI-Therapharma.